The characterization of Stat6 as a PR coregulator molecule involved in the antiproliferative and differentiation effects of progesterone in breast tissue could potentially explain the biological effects of different progestins on breast cancer and guide the future discovery of drugs. This evidence concerns the gene STAT6 and breast carcinoma.